Nature Biotechnology
18, 1125 (2000)
doi:10.1038/81031
ErrataOn p. 912 of the September issue, Cambridge Drug Discovery (Cambridge,
UK) was incorrectly cited as the acquisition target of Millennium Pharmaceuticals
(Cambridge, MA). Cambridge Discovery Chemistry (Cambridge, UK) was the company
that was acquired. In the same issue, on p. 940, the caption for Figure 2
should have read "Negative questions are reverse scored in this graph
so that in each case more positive or pro-biotechnology responses are toward
the left" rather than "toward the right." Also, on p. 1013,
the accompanying images for Nonlinear Dynamics' Phoretix Array2
and BioDiscovery's AutoGene software were reversed. On p. 1025
of the October issue, Alan Dove (not Natalie DeWitt) authored "A snare
for the weak."
|
